POLYMEDIX, INC Research and Development Expense
POLYMEDIX, INC reported Research and Development Expense of $3.18 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2012-11-09
- POLYMEDIX, INC research and development expense for the quarter ending 2012-09-30 was $3.18M, a 11.95% decline year-over-year.
- POLYMEDIX, INC research and development expense for the quarter ending 2012-06-30 was $3.44M, a 28.68% increase year-over-year.
- POLYMEDIX, INC research and development expense for the quarter ending 2012-03-31 was $4.57M, a 72.72% increase year-over-year.
- POLYMEDIX, INC research and development expense for the quarter ending 2011-12-31 was $47.77M, a 2084.04% increase year-over-year.
- POLYMEDIX, INC research and development expense for fiscal 2010 was $10.95M, a 48.51% increase from fiscal 2009.
- POLYMEDIX, INC research and development expense for fiscal 2009 was $7.37M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 107 month | Research and Development Expense 110 month | Research and Development Expense 113 month | Research and Development Expense 116 month | Research and Development Expense 119 month | Research and Development Expense 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $3.18M 10-Q · filed 2012-11-09 | $6.62M derived: sum of 2 quarters · filed 2012-11-09 | $11.18M 10-Q · filed 2012-11-09 | $58.95M derived: sum of 4 quarters · filed 2012-11-09 | $67.87M 10-Q · filed 2012-11-09 | ||||||
| 2012-06-30 | $3.44M 10-Q · filed 2012-08-09 | $8.01M 10-Q · filed 2012-08-09 | $55.77M derived: sum of 3 quarters · filed 2012-11-09 | $59.38M derived: sum of 4 quarters · filed 2012-11-09 | $64.70M 10-Q · filed 2012-08-09 | ||||||
| 2012-03-31 | $4.57M 10-Q · filed 2012-05-10 | $52.33M derived: sum of 2 quarters · filed 2012-11-09 | $55.94M derived: sum of 3 quarters · filed 2012-11-09 | $58.61M derived: sum of 4 quarters · filed 2012-11-09 | $61.26M 10-Q · filed 2012-05-10 | ||||||
| 2011-12-31 | $47.77M derived: 10-Q 12 month − 10-Q 9 month · filed 2012-11-09 | $51.37M derived: sum of 2 quarters · filed 2012-11-09 | $54.05M derived: sum of 3 quarters · filed 2012-11-09 | $56.69M 10-Q · filed 2012-11-09 | $13.78M 10-K · filed 2012-03-13 | $56.69M 10-K · filed 2012-03-13 | |||||
| 2011-09-30 | $3.61M 10-Q · filed 2012-11-09 | $6.28M derived: sum of 2 quarters · filed 2012-11-09 | $8.93M 10-Q · filed 2012-11-09 | $11.11M derived: sum of 4 quarters · filed 2012-11-09 | $51.84M 10-Q · filed 2011-11-09 | ||||||
| 2011-06-30 | $2.67M 10-Q · filed 2012-08-09 | $5.32M 10-Q · filed 2012-08-09 | $7.50M derived: sum of 3 quarters · filed 2012-08-09 | $10.28M derived: sum of 4 quarters · filed 2012-08-09 | $48.23M 10-Q · filed 2011-08-09 | ||||||
| 2011-03-31 | $2.64M 10-Q · filed 2012-05-10 | $4.83M derived: sum of 2 quarters · filed 2012-05-10 | $7.61M derived: sum of 3 quarters · filed 2012-05-10 | $10.78M derived: sum of 4 quarters · filed 2012-05-10 | |||||||
| 2010-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-13 | $4.96M derived: sum of 2 quarters · filed 2012-03-13 | $8.14M derived: sum of 3 quarters · filed 2012-03-13 | $10.95M 10-K · filed 2012-03-13 | |||||||
| 2010-09-30 | $2.77M 10-Q · filed 2011-11-09 | $5.95M derived: sum of 2 quarters · filed 2011-11-09 | $8.76M 10-Q · filed 2011-11-09 | ||||||||
| 2010-06-30 | $3.18M 10-Q · filed 2011-08-09 | $5.99M 10-Q · filed 2011-08-09 | |||||||||
| 2009-12-31 | $7.37M 10-K · filed 2012-03-13 |